Author

Simona Z Vasileva-Metodiev

Observed names: S. Vasileva Metodiev, S. Vasileva-Metodiev, S.Z. Vasileva-Metodiev, Simona Vasileva‐Metiodiev, Simona Vasileva‐Metodiev

Institution: Eli Lilly (United States)

Observed institutions: Eli Lilly (United States), Eli Lilly (United Kingdom)

ORCID: 0000-0003-2043-5661

Observed ORCID: 0000-0003-2043-5661

OpenAlex ID: A5115630504

Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

2025 · M. Schöll, A. Vrillon, et al. · The Journal of Prevention of Alzheimer s Disease · 48

Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey

2025 · Simona Z Vasileva-Metodiev, Drew Spargo, et al. · Journal of Alzheimer s Disease · 20

Real-world diagnosis and management of mild cognitive impairment and Alzheimer's disease dementia in the United Kingdom

2025 · Caroline S Casey, Niraj Patel, et al. · Journal of Alzheimer s Disease Reports · 2

Diagnostic journey and barriers to diagnosis for patients with mild cognitive impairment or dementia due to Alzheimer’s disease in Canada: results from a real‐world survey

2024 · Jennifer Glass, Luc Boulay, et al. · Alzheimer s & Dementia · 1

Predicting the Long‐Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN ‐1 Trial

2026 · Shraddha Shinde, Florian Kahles, et al. · Diabetes Obesity and Metabolism

Author response for "Predicting the long-term risk of type 2 diabetes and cardiovascular disease with orforglipron in people with overweight or obesity: a post-hoc analysis of the ATTAIN-1 trial"

2026 · Shraddha Shinde, Florian Kahles, et al. · Publons reviews and discussion

RWD5 Perspectives on Disease Burden Among Informal Care Partners of People With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease: A Real-World Survey

2024 · P. Sanchez-Juan, B. Botello Estrada, et al. · Value in Health

RWD42 Understanding the Treatment Landscape in Mild Cognitive Impairment/Alzheimer's Disease Dementia and Physicians’ Opinions on Future Developments in Disease-Modifying Therapies: A Real-World Survey

2024 · P. Sanchez-Juan, S. Vasileva-Metodiev, et al. · Value in Health

20969. El Proceso Diagnóstico De Las Personas Con Deterioro Cognitivo Leve Y Enfermedad De Alzheimer: Resultados De Una Encuesta Sobre La Práctica Clínica Real En España

2024 · M. Núñez Lozano, P. Sánchez-Juan, et al. · Neurology Perspectives

20972. Uso De Métodos Diagnósticos Y Biomarcadores En Pacientes Con Deterioro Cognitivo Leve O Enfermedad De Alzheimer: Resultados De Una Encuesta Sobre La Práctica Clínica Real En España

2024 · M. Núñez Lozano, P. Sánchez-Juan, et al. · Neurology Perspectives

Works count: 10

Citation count: 71

H-index: 2

I10-index: 2